Veralipride

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Veralipride
Veralipride.svg
Ball-and-stick model of the veralipride molecule
Systematic (IUPAC) name
N-[(1-Allylpyrrolidin-2-yl)methyl]-5-(aminosulfonyl)-2,3-dimethoxybenzamide
Clinical data
Legal status
  • (Prescription only)
Routes of
administration
Oral
Identifiers
CAS Registry Number 66644-81-3 YesY
ATC code N05AL06
PubChem CID: 47979
ChemSpider 43638 N
UNII S7064109UD YesY
Chemical data
Formula C17H25N3O5S
Molecular mass 383.4625 g/mol
 N (what is this?)  (verify)

Veralipride (Agreal, Agradil) is a benzamide neuroleptic medicine indicated in the treatment of vasomotor symptoms associated with the menopause. It was first authorised for use in 1979. Veralipride has never gained approval in the United States.

On September 2006, it was withdrawn from the Spanish market. As a result, the European Commission referred the matter to the European Medicines Agency (EMA). On July 2007, the EMA recommended the withdrawal of marketing authorisations for veralipride.[1]

See also[edit]

References[edit]